Hepatitis C virus RNA in factor VIII concentrates

Hepatitis C virus RNA in factor VIII concentrates BACKGROUND: Hepatitis C virus (HCV) RNA was measured in commercial factor VIII concentrates, that is, antihemophilic factor (human) (AHF), to allow the retrospective evaluation of the effect of various virus‐ inactivation procedures. The impact on AHF of recent anti‐HCV screening of plasma was also investigated. STUDY DESIGN AND METHODS: A total of 183 lots of AHF made by six United States‐licensed manufacturers from anti‐HCV‐unscreened (1976–1991) or screened (1992–1993) plasma were examined. Detection and quantitation of HCV RNA were achieved by reverse transcription and nested polymerase chain reaction at limiting dilution. Anti‐HCV in AHF was also measured. RESULTS: Earlier AHF lots subjected to non‐virus‐inactivated treatment (36 lots), dry heat (11 lots), or heating in n‐heptane (4 lots) had relatively high levels of HCV RNA. Most (76%) wet‐heated lots prepared before 1992 contained HCV RNA. No HCV RNA was detected in lots purified by immunoaffinity and subsequently heated or solvent/detergent (S/D)‐treated. However, trace levels of HCV RNA were detected in S/D‐treated lots made by one of four manufacturers before 1992. Since the start of anti‐HCV plasma screening in 1992, 38 lots prepared by six manufacturers were negative for HCV RNA. Prevalence of anti‐HCV was also associated with earlier concentrates and with S/D‐treated lots from that single manufacturer. CONCLUSION: Anti‐HCV screening of plasma by manufacturers in conjunction with current virus‐inactivation procedures, wet‐heating or S/D treatment (either process with or without affinity purification), appears to reduce HCV RNA to undetectable levels in AHF. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Transfusion Wiley

Hepatitis C virus RNA in factor VIII concentrates

Loading next page...
 
/lp/wiley/hepatitis-c-virus-rna-in-factor-viii-concentrates-rGatP0lbIR
Publisher site
See Article on Publisher Site

Abstract

BACKGROUND: Hepatitis C virus (HCV) RNA was measured in commercial factor VIII concentrates, that is, antihemophilic factor (human) (AHF), to allow the retrospective evaluation of the effect of various virus‐ inactivation procedures. The impact on AHF of recent anti‐HCV screening of plasma was also investigated. STUDY DESIGN AND METHODS: A total of 183 lots of AHF made by six United States‐licensed manufacturers from anti‐HCV‐unscreened (1976–1991) or screened (1992–1993) plasma were examined. Detection and quantitation of HCV RNA were achieved by reverse transcription and nested polymerase chain reaction at limiting dilution. Anti‐HCV in AHF was also measured. RESULTS: Earlier AHF lots subjected to non‐virus‐inactivated treatment (36 lots), dry heat (11 lots), or heating in n‐heptane (4 lots) had relatively high levels of HCV RNA. Most (76%) wet‐heated lots prepared before 1992 contained HCV RNA. No HCV RNA was detected in lots purified by immunoaffinity and subsequently heated or solvent/detergent (S/D)‐treated. However, trace levels of HCV RNA were detected in S/D‐treated lots made by one of four manufacturers before 1992. Since the start of anti‐HCV plasma screening in 1992, 38 lots prepared by six manufacturers were negative for HCV RNA. Prevalence of anti‐HCV was also associated with earlier concentrates and with S/D‐treated lots from that single manufacturer. CONCLUSION: Anti‐HCV screening of plasma by manufacturers in conjunction with current virus‐inactivation procedures, wet‐heating or S/D treatment (either process with or without affinity purification), appears to reduce HCV RNA to undetectable levels in AHF.

Journal

TransfusionWiley

Published: Feb 1, 1995

References

  • Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates
    Mannucci, Mannucci
  • Partitioning of hepatitis C virus during Cohn‐Oncley fractionation of plasma
    Yei, Yei; Yu, Yu; Tankersley, Tankersley
  • Detection and characterization of hepatitis C virus RNA in immune globulins
    Yu, Yu; Mason, Mason; Tankersley, Tankersley

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off